Trademark Overview
On Tuesday, May 13, 2025, a trademark application was filed for KAMADA with the United States Patent and Trademark Office. The USPTO has given the KAMADA trademark a serial number of 99182288. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Friday, September 26, 2025. This trademark is owned by Kamada Ltd.. The KAMADA trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceuticals, namely, plasma derived and recombinant immunoglobulins; pharmaceuticals, namely, plasma derived and recombinant proteins for treating pulmonary diseases, congenital Alpha-1 Antitrypsin deficiency, post-exposure prophylaxis against viral infection, preventing and treating immune tolerance based diseases, treating immunological disorders and treating inflammatory diseases; pharmaceuticals, namely, coagulation factors for bleeding disorders; plasma-derived protein preparations for therapeutic use; vaccines; pharmaceutical preparations for the treatment of lung diseases; pharmaceutical preparations for the treatment or prevention of thrombo-embolic disorders; pharmaceutical preparations for anesthesia or analgesia for surgery; pharmaceutical preparations for treatment of CMV infection and disease; pharmaceutical preparations for treatment of Varicella Zoster Virus; pharmaceutical preparations for treatment of Hepatitis; pharmaceutical preparations for treatment of Rabies
